ライフサイエンスコーパス: immunoglobulin A

1 other salivary proteins, including secretory immunoglobulin A.

2 aximal development of RV-specific intestinal immunoglobulin A.

3 or the milk as immunoglobulin G and secreted immunoglobulin A.

4 the apical recycling marker, membrane-bound immunoglobulin A (a ligand for the polymeric immunoglobu

5 its analysed were faecal egg count (FEC) and immunoglobulin A activity against third-stage larvae fro

6 sies in children with symptoms and levels of immunoglobulin A against tissue-transglutaminase (TGA-Ig

7 Therefore, a complex enriched in secretory immunoglobulin A and alpha-amylase forms a S. sanguis-bi

8 In addition, immunoglobulin A and bactericidal antibodies were detect

9 in reactions, and mucosal defense (secretory immunoglobulin A and dual-sugar permeability).

10 fic circulating immunoglobulin G and vaginal immunoglobulin A and G antibodies.

11 In the MR + HRV group, antirotavirus immunoglobulin A and IgG seropositivity frequencies befo

12 The route of vaccination did not affect the immunoglobulin A and immunoglobulin G (IgG) plasmablast

13 Elevated serum immunoglobulin A and immunoglobulin G titers were associ

14 rforation plus immunoglobulins enriched with immunoglobulin A and immunoglobulin M (250 mg/kg, intrav

15 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M (p < .01).

16 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M alleviated the sym

17 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M improve the integr

18 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M on blood-brain bar

19 oglobulin G or immunoglobulins enriched with immunoglobulin A and immunoglobulin M treatment, no ultr

20 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M, respectively (p <

21 erol levels and gallstones risk; and between immunoglobulin A and juvenile idiopathic arthritis).

22 Flow rate and salivary concentrations of immunoglobulins A and G, albumin, amylase, lysozyme, lac

23 Pan-immunoglobulin, immunoglobulin A, and histo-blood group antigen-blocking

24 Serum levels of immunoglobulin M, immunoglobulin A, and immunoglobulin G against C. diffic

25 um total free light chain, immunoglobulin G, immunoglobulin A, and immunoglobulin M were measured on

26 CDAT score and anti-tissue transglutaminase immunoglobulin A (anti-t-TG-IgA) titer was assessed.

27 unosorbent assay titers in serum and mucosal immunoglobulin A antibodies against H3N2 SIV antigens.

28 Norwalk VLP-specific immunoglobulin G and immunoglobulin A antibodies increased 4.8- and 9.1-fold,

29 c mean mucosal (fecal and salivary) anti-HWC immunoglobulin A antibodies occurred among H. pylori-inf

30 ke virus, and sera were drawn and tested for immunoglobulin A antibodies to the outbreak strain.

31 (SARS-CoV-2), including immunoglobulin G and immunoglobulin A antibodies.

32 ced a local mucosal response as evidenced by immunoglobulin A antibody in saliva, nasal washes, and l

33 Immunoglobulin A antibody levels that are elevated befor

34 unoglobulin G and A, and nasal wash specimen immunoglobulin A antibody responses to the HMPV F protei

35 A dose-related, immunoglobulin A antibody-secreting cell (ASC) response

36 blood flow had more abdominal discomfort and immunoglobulin A-antilipopolysaccharide (r = 0.76, p < 0

37 ed the 50- or 100-mug vaccine dose developed immunoglobulin A ASCs.

38 a distinct signature consisting of elevated immunoglobulin A autoantibodies and interleukin-23 was o

39 icroneutralization, and immunoglobulin G and immunoglobulin A (both serum and mucosal antibodies) and

40 study of Bangladeshi children, greater fecal immunoglobulin A, but not plasma immunoglobulin G, direc

41 his relationship was particularly strong for immunoglobulin A clones (R, 1; P < 0.0005), suggesting t

42 advantageous in vivo, and increased anti-CPS immunoglobulin A correlated with increased fitness of a

43 Selective immunoglobulin A deficiency (IgAD) is the most common pr

44 tand the genetic predisposition to selective immunoglobulin A deficiency (IgAD), we performed a genom

45 -syndrome, common variable immunodeficiency, immunoglobulin A deficiency, or X-linked hyper-IgM syndr

46 s membrane pemphigoid, lichen planus, linear immunoglobulin A disease, and chronic ulcerative stomati

47 ases studied except for pemphigus and linear immunoglobulin A disease.

48 Immunoglobulin A enzyme-linked immunosorbent assays to A

49 Immunoglobulin A, for example, was induced to a signific

50 ssay to measure levels of total antireovirus immunoglobulin A, G, and M in serum specimens collected

51 Fragments from the immunoglobulin A gene were also found to have RNA polyme

52 Mice lacking immunoglobulin A had no defect in their ability to contr

53 tions containing T. cruzi-specific secretory immunoglobulin A harvested from immune mice were shown t

54 Basolateral-to-apical transcytosis of immunoglobulin A (IgA) (a ligand for the polymeric immun

55 stinal M cells bear a receptor for secretory immunoglobulin A (IgA) (sIgA) facing the lumen of the ep

56 As) for BP180 and BP230 (MBL International), immunoglobulin A (IgA) A and immunoglobulin G indirect i

57 Transport of immunoglobulin A (IgA) across the mucosa to the gut lume

58 samples were collected in October from which immunoglobulin A (IgA) activity was measured and DNA was

59 al extracts were assayed for total secretory immunoglobulin A (IgA) and C. parvum-specific IgA reacti

60 llele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (

61 scribe patterns and determinants of cervical immunoglobulin A (IgA) and G (IgG) levels during the men

62 ination inhibition, microneutralization, and immunoglobulin A (IgA) and G enzyme-linked immunosorbent

63 ificantly higher plasma and mucosal anti-SBR immunoglobulin A (IgA) and IgG Ab responses than SBR alo

64 ated the prevalence of abnormally high serum immunoglobulin A (IgA) and IgG anti-gliadin antibody tit

65 gh i.vag. immunization induced local vaginal immunoglobulin A (IgA) and IgG antibody responses, these

66 allenge, total HRV- and HRV protein-specific immunoglobulin A (IgA) and IgG ASCs in intestinal lympho

67 Influenza virus-specific effector immunoglobulin A (IgA) and IgG circulating antibody-secr

68 d a significantly dose-dependent increase of immunoglobulin A (IgA) and IgG in the nasal wash, lung l

69 ficient mice had elevated baseline levels of immunoglobulin A (IgA) and IgG in the serum and increase

70 toxin (CT), elicited comparable SEB-specific immunoglobulin A (IgA) and IgG levels in saliva.

71 all volunteers who received H10407 had serum immunoglobulin A (IgA) and IgG responses, and all but on

72 ids contained significantly higher levels of immunoglobulin A (IgA) and IgG specific for each protein

73 induction of antigen-specific genital tract immunoglobulin A (IgA) and IgG.

74 tained within the vaccine vector, diminished immunoglobulin A (IgA) and IgG1 antibody titers, as well

75 A (ConA) plus CT enhanced the production of immunoglobulin A (IgA) and IgM by dividing cells that ex

76 Influenza virus-specific immunoglobulin A (IgA) and immunoglobulin G (IgG) antibo

77 Pre-F immunoglobulin A (IgA) and immunoglobulin G (IgG) antibo

78 Serum immunoglobulin A (IgA) and immunoglobulin G (IgG), fecal

79 revalence and level of intestinal antilectin immunoglobulin A (IgA) and serum anti-LC3 (cysteine-rich

80 Fecal immunoglobulin A (IgA) and serum IgG antibodies were fir

81 ed with elevated levels of antitoxin mucosal immunoglobulin A (IgA) and serum IgG antibodies.

82 were collected; anti-P. gingivalis salivary immunoglobulin A (IgA) and serum IgG were quantified.

83 ccinated mice produced CRR-specific salivary immunoglobulin A (IgA) and serum IgG.

84 explains the observed elevations in mucosal immunoglobulin A (IgA) and serum IgG1 antibodies.

85 or optimal induction of protective secretory immunoglobulin A (IgA) and systemic type 1 immunity prot

86 ng antibodies, promotes systemic and mucosal immunoglobulin A (IgA) and T cell responses, and almost

87 seroconverted, and 100% coproconverted with immunoglobulin A (IgA) and/or IgG antibodies to HuNoV-HS

88 gher levels of salivary, plasma, and vaginal immunoglobulin A (IgA) anti-C-GTF responses and higher l

89 Immunoglobulin A (IgA) antibodies are presumed to be imp

90 that were recognized by intestinal secretory immunoglobulin A (IgA) antibodies from immune human subj

91 2-fold increase in influenza virus-specific immunoglobulin A (IgA) antibodies in nasal wash.

92 c virus-neutralizing antibodies in serum and immunoglobulin A (IgA) antibodies in secretions at the r

93 c virus neutralizing antibodies in serum and immunoglobulin A (IgA) antibodies in secretions at the r

94 generate massive amounts of noninflammatory immunoglobulin A (IgA) antibodies through multiple folli

95 a were tested for immunoglobulin G (IgG) and immunoglobulin A (IgA) antibodies to Cryptosporidium and

96 Immunoglobulin A (IgA) antibodies to tissue transglutami

97 Immunoglobulin A (IgA) antibodies, produced in the lamin

98 functions, including induction of protective immunoglobulin A (IgA) antibodies.

99 e for a protective role for Candida-specific immunoglobulin A (IgA) antibodies.

100 We used a human monoclonal immunoglobulin A (IgA) antibody (NAD) to type 8 Streptoc

101 immunity to ricin correlates with secretory immunoglobulin A (IgA) antibody levels in vivo, the pote

102 nked immunosorbent assay that the intestinal immunoglobulin A (IgA) antibody response to the Entamoeb

103 consistently displayed greater anti-envelope immunoglobulin A (IgA) antibody responses in bronchoalve

104 V1 and RV5 to correlate anti-rotavirus serum immunoglobulin A (IgA) antibody titers vs efficacy in re

105 After nasal immunization, antigen-specific immunoglobulin A (IgA) antibody-forming cells dominated

106 Large quantities of immunoglobulin A (IgA) are constitutively secreted by in

107 rum-neutralizing antibody and anti-rotavirus immunoglobulin A (IgA) are the current standard for asse

108 threshold of postvaccine serum antirotavirus immunoglobulin A (IgA) as an individual-level immune cor

109 lated the highest mean numbers of intestinal immunoglobulin A (IgA) ASCs prechallenge among all vacci

110 Our data suggest that anti-FVIII immunoglobulin A (IgA) autoantibodies are predictors of

111 Monomeric serum immunoglobulin A (IgA) can contribute to the development

112 Antibodies of the immunoglobulin A (IgA) class react with capsular polysac

113 the active gut mucosal immune responses, and immunoglobulin A (IgA) coating of SFB in the gut.

114 Mucosal immunoglobulin A (IgA) deficiency in the gut resulted in

115 The levels of immunoglobulin A (IgA) detected in rectal secretions of

116 for neutralization of poliovirus and mucosal immunoglobulin A (IgA) detection.

117 Intestinal immunoglobulin A (IgA) ensures host defense and symbiosi

118 Significantly, mice genetically deficient in immunoglobulin A (IgA) expression were unable to survive

119 rgans for the generation of T cell-dependent immunoglobulin A (IgA) for gut homeostasis.

120 ne immunogenicity, the quantity of rotavirus immunoglobulin A (IgA) in stool specimens obtained, at 1

121 ixture of these strains, developed secretory immunoglobulin A (IgA) in tears and serum IgG antibodies

122 Immunoglobulin A (IgA) induction primarily occurs in int

123 Immunoglobulin A (IgA) is a glycoprotein of which altere

124 Here we show that maternal immunoglobulin A (IgA) is an important factor for protec

125 Immunoglobulin A (IgA) is prominently secreted at mucosa

126 locally driven response in the mucosa, where immunoglobulin A (IgA) is the dominant antibody isotype.

127 Immunoglobulin A (IgA) is the main intestinal antibody.

128 Immunoglobulin A (IgA) is the major secretory immunoglob

129 Immunoglobulin A (IgA) is the most abundant immunoglobul

130 Human immunoglobulin A (IgA) is the most prevalent antibody cl

131 The results showed that immunoglobulin A (IgA) is the predominant M. catarrhalis

132 Immunoglobulin A (IgA) is the primary immune response in

133 negative regulator of class switching to the immunoglobulin A (IgA) isotype.

134 The salivary immunoglobulin A (IgA) level was measured by an enzyme-l

135 inked immunosorbent assay (ELISA), and fecal immunoglobulin A (IgA) levels determined by ELISA.

136 Norovirus-specific immunoglobulin A (IgA) levels in baseline saliva samples

137 in the HIV-1+ infants, whereas antirotavirus immunoglobulin A (IgA) levels were not.

138 amina propria lymphocytes, lowers gut and RT immunoglobulin A (IgA) levels, and destroys established

139 ffects of epitope-specific murine antilectin immunoglobulin A (IgA) monoclonal antibodies (MAbs) on a

140 A common renal disease, immunoglobulin A (IgA) nephropathy (IgAN), is associated

141 TG2-specific immunoglobulin A (IgA) of plasma cells (PCs) from CD les

142 mmals and birds, these species are devoid of immunoglobulin A (IgA) or a functional equivalent.

143 uce detectable levels of mucosal or systemic immunoglobulin A (IgA) or IgG antibody responses to eith

144 ng a multiplex immunoassay, we tested plasma immunoglobulin A (IgA) or immunoglobulin G (IgG) levels

145 Immunoglobulin A (IgA) produced by mucosal B cells dicta

146 nodes (MLNs) are thought to be essential for immunoglobulin A (IgA) production.

147 gene with high homology to the meningococcal immunoglobulin A (IgA) protease gene, which is distinct

148 The immunoglobulin A (IgA) protease secreted by pathogenic N

149 BatB is predicted to share similarity with immunoglobulin A (IgA) proteases, and we showed that Bat

150 Secretory immunoglobulin A (IgA) protects the mucosal surfaces aga

151 Immunoglobulin A (IgA) provides protection against patho

152 f of the volunteers mounted a positive serum immunoglobulin A (IgA) response to S. flexneri lipopolys

153 fected with C. rodentium develop a secretory immunoglobulin A (IgA) response, but the role of B cells

154 al immunization induced greater HIV-specific immunoglobulin A (IgA) responses in mucosal secretions a

155 Protective immunoglobulin A (IgA) responses to oral antigens are us

156 We also measured immunoglobulin A (IgA) responses to the parasite, as IgA

157 Salivary immunoglobulin A (IgA) responses were not detected after

158 ut causing disease while eliciting secretory immunoglobulin A (IgA) responses, as evidenced by gut ti

159 -12 (IL-12) can stimulate elevated secretory immunoglobulin A (IgA) responses.

160 Mucosal immunoglobulin A (IgA) secreted by local plasma cells (P

161 ction and abrogates M. tuberculosis-specific immunoglobulin A (IgA) secretion to respiratory airways

162 We compared serum antirotavirus immunoglobulin A (IgA) seroconversion (>/=20 U/mL) and g

163 sponse were examined including antirotavirus immunoglobulin A (IgA) seroconversion (defined as the ap

164 [OR], 0.77; P = .002) and lack of rotavirus immunoglobulin A (IgA) seroconversion (OR, 1.95; P = .01

165 imary objective was to compare antirotavirus immunoglobulin A (IgA) seroconversion at 18 weeks in the

166 2D6 is a dimeric monoclonal immunoglobulin A (IgA) specific for the nonreducing term

167 ncrease in meningococcus-specific intranasal immunoglobulin A (IgA) titers, while 23 of 42 demonstrat

168 e and 551 HIV-negative women were tested for immunoglobulin A (IgA) to human papillomavirus (HPV) typ

169 philic granulomatosis with polyangiitis, and immunoglobulin A (IgA) vasculitis by analysing BCR clona

170 cells producing antilipopolysaccharide (LPS) immunoglobulin A (IgA) were detected in 100 and 92% of r

171 Mice that lack immunoglobulin A (IgA) were fully protected, suggesting

172 ll responses by increasing the production of immunoglobulin A (IgA) while decreasing the production o

173 BCP also binds human immunoglobulin A (IgA), a characteristic that may be und

174 This dialog causes massive production of immunoglobulin A (IgA), a non-inflammatory antibody spec

175 CD8(-/-) mice had increased serum levels of immunoglobulin A (IgA), AMA and interleukin-17 (IL-17).

176 antibody and NS for neutralizing (neut), NI, immunoglobulin A (IgA), and immunoglobulin G (IgG) anti-

177 osal vaccine evoked high secretory titers of immunoglobulin A (IgA), as well as high circulating tite

178 d significant roles of RV-specific secretory immunoglobulin A (IgA), CD4+ T cells, and CD8+ T cells i

179 studied using T helper 1 cytokines/secretory immunoglobulin A (IgA), histatins and lysozyme in a subs

180 nt assay for group C polysaccharide-specific immunoglobulin A (IgA), IgA1, IgA2 and secretory compone

181 vaccine elicited S. flexneri 2a LPS-specific immunoglobulin A (IgA), IgG, and IgM antibody-secreting

182 ermine the phenotype of leukocytes and total immunoglobulin A (IgA), IgG, and IgM titers in the saliv

183 Three defense functions of immunoglobulin A (IgA), immune exclusion, intracellular

184 , the receptor specific for the Fc region of immunoglobulin A (IgA), is responsible for IgA-mediated

185 Immunoglobulin A (IgA), the major class of antibody secr

186 Immunoglobulin A (IgA), the most abundant human immunogl

187 a gonorrhoeae, produce proteases that cleave immunoglobulin A (IgA), the predominant immunoglobulin c

188 We hypothesized that immunoglobulin A (IgA), the predominant mucosal antibody

189 induced Frag C-specific mucosal and systemic immunoglobulin A (IgA)- and IgG-secreting cells, T-cell

190 nd CD8(+) cells and a sizeable population of immunoglobulin A (IgA)- and IgG-secreting plasma cells.

191 6 (IL-6) was required for the development of immunoglobulin A (IgA)- and T-helper 1 (Th1)-associated

192 tly generated and characterized a new murine immunoglobulin A (IgA)-class monoclonal antibody (MAb),

193 nd secondary chlamydial genital infection in immunoglobulin A (IgA)-deficient (IgA(-/-)) mice was not

194 sentation of ovalbumin (OVA) internalized as immunoglobulin A (IgA)-OVA via the IgA Fc receptor (Fcal

195 Humoral immune responses, particularly immunoglobulin A (IgA)-secreting B-1 cells, play a criti

196 Normal intestinal mucosa contains abundant immunoglobulin A (IgA)-secreting cells, which are genera

197 icrobial peptides, and mucosal production of immunoglobulin A (IgA).

198 litis (EAE) originate in the gut and produce immunoglobulin A (IgA).

199 is necessary for the induction of intestinal immunoglobulin A (IgA).

200 , bovine submaxillary gland mucin, and serum immunoglobulin A (IgA).

201 ic coating of the intestinal microbiota with immunoglobulin A (IgA-SEQ) and show that high IgA coatin

202 w that microbially driven dichotomous faecal immunoglobulin-A (IgA) levels in wild-type mice within t

203 The genetic component of Immunoglobulin-A (IgA) vasculitis is still far to be elu

204 tibodies to Helicobacter pylori [isotypes of immunoglobulins A (IgA), G (IgG), and M (IgM)], hepatiti

205 to characterize mucosal (salivary and fecal immunoglobulin A [IgA]) and cellular (NV-specific IgA an

206 e investigated humoral and mucosal (salivary immunoglobulin A [IgA]) immune responses in a phase 2 tr

207 cessible to a membrane-bound marker (dimeric immunoglobulin A [IgA]) internalized from either the api

208 We report isotype-specific (immunoglobulin A [IgA], IgE, IgG1, IgG4, and IgG) antibo

209 measure levels of total and Candida-specific immunoglobulin A(IgA) and IgG antibodies, including subc

210 H. pylori serum immunoglobulin A, IgG, and IgG subclass responses were d

211 Consequent immunoglobulin A immunity and microbial niche competitio

212 [PMN elastase], and total protein, albumin, immunoglobulin A, immunoglobulin G, and immunoglobulin M

213 DMBT1(gp-340), mucin-7, secretory component, immunoglobulin A, immunoglobulin G, S100-A9, and lysozym

214 ubjects had a 4-fold rise in serum levels of immunoglobulin A, immunoglobulin M, or immunoglobulin G.

215 Serology screening of total immunoglobulin A in all patients may not be necessary in

216 ort study, the presence of parasite-specific immunoglobulin A in breast milk was associated with prot

217 llular permeability, normalized anti-gliadin immunoglobulin A in intestinal washes, and modulated the

218 es in sera and of peptide-specific secretory immunoglobulin A in nasal secretions.

219 tibody (anti-EMA), had total serum levels of immunoglobulin A in the normal range, normal duodenal ar

220 the presence of elevated levels of anti-MBP immunoglobulin A in the tear fluid of the immunized anim

221 ling polymeric immunoglobulin receptor-bound immunoglobulin A is delivered to a Rab11-positive subapi

222 in serotypes 2 and 3, and although salivary immunoglobulin A is significantly increased in serotypes

223 Immunoglobulin A is the dominant antibody isotype found

224 Immunoglobulin A isolated from immunized animals bound M

225 onal antibody against PDC-E2 and AMA with an immunoglobulin A isotype.

226 1.8-fold increase in total small intestinal immunoglobulin A levels (P = 0.003) and a 4.4-fold incre

227 range: 2.0-2.3 x 10(3)/microl, p = 0.05) and immunoglobulin A levels (range: 210-252 mg/dl, p = 0.04)

228 the monoclonal antibody, and serum anti-OmpW immunoglobulin A levels were elevated in a Crohn's disea

229 Salivary albumin and immunoglobulin A levels were relatively low in these pat

230 le family members showed only elevated serum immunoglobulin A levels.

231 obulin G titers (median, 1:51,200) and lower immunoglobulin A (median, 1:3,200) and immunoglobulin E

232 iscovered that these microbial products have immunoglobulin A-modulatory activity.

233 HRa, 0.90; 95% CI, 0.32-2.52) but present in immunoglobulin A nephropathy (HRa, 0.74; 95% CI, 0.59-0.

234 ow T cells contribute to the pathogenesis of immunoglobulin A nephropathy (IgAN) has not been well de

235 identified multiple susceptibility loci for immunoglobulin A nephropathy (IgAN), the most common for

236 Concurrent immune diseases are common, and immunoglobulin A nephropathy may explain ascites in some

237 Immunoglobulin A nephropathy results from the abnormal d

238 confidence interval [95% CI], 1.05-1.31) for immunoglobulin A nephropathy to 2.09 (95% CI, 1.56-2.78)

239 iabetic nephropathy, membranous nephropathy, immunoglobulin A nephropathy, and autosomal dominant pol

240 d as an RV3-BB serum immune response (either immunoglobulin A or serum neutralizing antibody) and/or

241 luenza virus immunoglobulin G (P < .001) and immunoglobulin A (P < .001) titers than recipients of Fl

242 nificant increases in LAM-reactive secretory immunoglobulin A (P<.05).

243 GC origin identified 6 lines lacking surface immunoglobulin, a phenotype never seen among lines deriv

244 We have previously reported that oligoclonal immunoglobulin A plasma cells infiltrate acute KD tissue

245 Immunoglobulin A plasma cells infiltrate inflamed tissue

246 lly, LAIV induced a greater vaccine-specific immunoglobulin A plasmablast response, as well as a grea

247 Treatment with intravenous immunoglobulins (a preparation that contained anti-A bet

248 creased small intestinal rotavirus-specific, immunoglobulin A-producing antibody-secreting cell conce

249 ccompanied by accumulation of liver-resident immunoglobulin-A-producing (IgA(+)) cells.

250 ORC2 impaired CD4(+) T cell accumulation and immunoglobulin A production and aberrantly induced the t

251 olled infections only slowly although normal immunoglobulin A production was observed.

252 S, whereas LPS immunization resulted in only immunoglobulin A production.

253 here the first structure of a member of the immunoglobulin A protease (IgAP) family at 1.75-A resolu

254 zing with a probe to iga, a gene encoding an immunoglobulin A protease of H. influenzae, clustered ap

255 ccine by the intrarectal route and a limited immunoglobulin A response at the same site.

256 Moreover, a substantial mucosal immunoglobulin A response was induced in the respiratory

257 Rare mucosal immunoglobulin A responses and no measurable vaccine-eli

258 y an important role in the higher intestinal immunoglobulin A responses and protection rates induced

259 17-producing helper T cell (T(H)17 cell) and immunoglobulin A responses critically required expressio

260 In contrast, adaptive immunoglobulin A responses to symbiotic bacteria regulat

261 T cells, the epithelial barrier, and healthy immunoglobulin A responses to the gut commensals.

262 In contrast, more mucosal immunoglobulin A responses were seen with LAIV.

263 anti-lipopolysaccharide immunoglobulin G and immunoglobulin A responses were significantly correlated

264 tination inhibition titers, enhanced mucosal immunoglobulin A responses, and enhanced antigen present

265 n introduced through microfold cells induces immunoglobulin A responses, antigen delivered by goblet

266 or optimal induction of protective secretory immunoglobulin A responses.

267 e with the development of commensal-specific immunoglobulin A responses.

268 Each had plasmablastic morphology, showed immunoglobulin A restriction, and was ALK positive and C

269 e and, if so, whether antireovirus secretory immunoglobulin A (S-IgA) is a necessary component of pro

270 ted inquiry into the regulation of secretory immunoglobulin A (S-IgA) responses by substance P (SP) a

271 We evaluated antirotavirus immunoglobulin A seroconversion ('vaccine take") among 1

272 ere seronegative at baseline, anti-rotavirus immunoglobulin A seroconversion rates after 3 vaccine do

273 S-transferase fusion protein showed frequent immunoglobulin A seroreactivity in CD (54% of patients),

274 otein C (PspC) binds to both human secretory immunoglobulin A (sIgA) and complement factor H (FH).

275 Secretory immunoglobulin A (SIgA) antibodies directed against the

276 In addition, secretory immunoglobulin A (sIgA) antibodies were detected in the

277 chemical approaches to investigate secretory immunoglobulin A (SIgA) as a substrate of BV-associated

278 PspK bound human secretory immunoglobulin A (sIgA) but not the complement regulator

279 re the association between natural secretory immunoglobulin A (sIgA) capsular antibodies in breast mi

280 As secretory immunoglobulin A (SIgA) deficiency in small airways has

281 Secretory immunoglobulin A (SIgA) enhances host-microbiota symbios

282 meability and elevated circulating secretory immunoglobulin A (sIgA) in KD patients, as well as eleva

283 Secretory immunoglobulin A (SIgA) is the single most abundant acqu

284 Secretory immunoglobulin A (sIgA) represents the immune system's f

285 ermore, it expresses receptors for secretory immunoglobulin A (SIgA), the main antibody in mucosal se

286 The binding of human secretory immunoglobulin A (SIgA), the primary immunoglobulin in t

287 ase and promotes retrotransport of secretory immunoglobulin A (SIgA)-gliadin complexes.

288 y pathway that involves intestinal secretory immunoglobulin A (sIgA).

289 sensitive, and noninvasive determination of immunoglobulins A specific to SARS-CoV-2 (IgA) in saliva

290 lication of SseB-MB induced gut and systemic immunoglobulin A, T-helper type 17 cell (Th17), and Th1

291 Inappropriate immunoglobulin A targeting of Clostridia and increased D

292 of CD, particularly tissue transglutaminase-immunoglobulin A (TG2-IgA), IgA testing, and less freque

293 roconversion was defined as a 4-fold rise in immunoglobulin A titer from before the first RV1 dose to

294 Two of 15 workers at caterer A had elevated immunoglobulin A titers to an antigenically related Norw

295 zation and induction of immunoglobulin G and immunoglobulin A to all antigens tested, while causing n

296 sed levels of antiplatelet antibodies of the immunoglobulin A type in the milk of ITP patients compar

297 Circulating levels of immunoglobulin A, vascular cell adhesion molecule-1, mye

298 anti-galactose/N-acetylgalactosamine lectin immunoglobulin A was associated with protection from rei

299 Plasma rotavirus-specific immunoglobulin A was determined by ELISA pre- and post-i

300 Vaginal FIV-specific immunoglobulin A was present at high titer in three LMga